arrow
N

Noe B. Mercado

Beth Israel Deaconess Medical Center
H指数:25
被引数:8,246

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
2022-06-1620
OAAI
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
2022-05-187
OAAI
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques

HBsAg病毒样颗粒上显示的SARS-CoV-2受体结合域在猕猴中引起保护性免疫

2022-03-1822
OAAI
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
2022-01-2610
OAAI
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
Nature
IF48.5
2021-11-180
OAAI
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
2021-11-0330
OAAI
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
2021-11-0316
OAAI
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
2021-10-0720
OAAI
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
2021-03-0527
OAAI
Correlates of protection against SARS-CoV-2 in rhesus macaques
Nature
IF48.5
2020-12-040
PREAI
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
2020-09-03231
OAAI
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature
IF48.5
2020-07-150
PREAI
Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C
2020-05-047
OAAI